Basic Information
EMSAM
49502-900
Regulatory Information
49502-900
NDA021336
C73594
May 15, 2020
USA
These highlights do not include all the information needed to use EMSAM safely and effectively. See full prescribing information for EMSAM. EMSAM (selegiline transdermal system) Initial U.S. Approval: 2006
HUMAN PRESCRIPTION DRUG LABEL
16
Company Information
194775557
Active Ingredients
Active Moieties
SELEGILINE
Code: 2K1V7GP655